467 related articles for article (PubMed ID: 27044796)
21. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
Sachar M; Shah A
Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
[TBL] [Abstract][Full Text] [Related]
22. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
[TBL] [Abstract][Full Text] [Related]
23. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
24. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children.
Chua AN; Goldstein SL; Bell D; Brewer ED
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1939-43. PubMed ID: 19820132
[TBL] [Abstract][Full Text] [Related]
25. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
[TBL] [Abstract][Full Text] [Related]
26. Effect of Local Polyhexanide Application in Preventing Exit-Site Infection and Peritonitis: A Randomized Controlled Trial.
Ceri M; Yilmaz SR; Unverdi S; Kurultak I; Duranay M
Ther Apher Dial; 2020 Feb; 24(1):81-84. PubMed ID: 31066988
[TBL] [Abstract][Full Text] [Related]
27. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
Ritzau J; Hoffman RM; Tzamaloukas AH
Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
[TBL] [Abstract][Full Text] [Related]
28. Exit site infections: systematic microbiologic and quality control are needed.
Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
[TBL] [Abstract][Full Text] [Related]
29. Erosion of the Silicone Peritoneal Dialysis Catheter with the Use of Gentamicin Cream at the Exit Site.
Gardezi AI; Schlageter KW; Foster DM; Astor BC; Chan MR; Waheed S
Adv Perit Dial; 2016; 32():15-18. PubMed ID: 28988584
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
Jassal SV; Lok CE;
Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
32. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
[TBL] [Abstract][Full Text] [Related]
33. Water avoidance and modification of exit-site care with stoma bag results in reduced exit-site infection rate in peritoneal dialysis patients.
Soetendorp H; Kliuk-Ben Bassat O; Wasserman A; Schwartz D; Bedbalayev R; Faukman I; Grupper A
Clin Nephrol; 2021 Jun; 95(6):323-331. PubMed ID: 33835011
[TBL] [Abstract][Full Text] [Related]
34. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.
Xu G; Tu W; Xu C
Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557
[TBL] [Abstract][Full Text] [Related]
35. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
van Diepen AT; Tomlinson GA; Jassal SV
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1266-71. PubMed ID: 22745277
[TBL] [Abstract][Full Text] [Related]
36. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.
Lim CT; Wong KS; Foo MW
Nephrol Dial Transplant; 2005 Oct; 20(10):2202-6. PubMed ID: 16046516
[TBL] [Abstract][Full Text] [Related]
37. Preventing Peritoneal Dialysis Infections.
Bolton L
Wounds; 2019 Jun; 31(6):163-165. PubMed ID: 31215869
[TBL] [Abstract][Full Text] [Related]
38. 32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.
van Esch S; Krediet RT; Struijk DG
Perit Dial Int; 2014; 34(2):162-70. PubMed ID: 24584620
[TBL] [Abstract][Full Text] [Related]
39. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.
Restrepo C; Chacon J; Manjarres G
Perit Dial Int; 2010; 30(6):619-25. PubMed ID: 20634438
[TBL] [Abstract][Full Text] [Related]
40. Prevention of peritonitis in peritoneal dialysis.
Segal JH; Messana JM
Semin Dial; 2013; 26(4):494-502. PubMed ID: 23859192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
